Pages

Tuesday, June 27, 2017

FDA Approves Daratumumab in Combination With Pomalidomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

This is my current mix...


http://www.ascopost.com/News/57747
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Berenson Oncology Success Rate

 Some reading about my myeloma specialist's success rate. A press release and an article from Targeted Oncology.